Literature DB >> 17290396

Frequent overexpression of the genes FXR1, CLAPM1 and EIF4G located on amplicon 3q26-27 in squamous cell carcinoma of the lung.

Nicole Comtesse1, Andreas Keller, Isabel Diesinger, Christine Bauer, Klaus Kayser, Hanno Huwer, Hans-Peter Lenhof, Eckart Meese.   

Abstract

Previously, we reported gene amplification at chromosome 3q26-27 in more than one third of squamous cell carcinomas of the lung. Frequent amplification of eukaryotic translation initiation factor 4G on 3q27.1 indicated a possible role of this amplification in translation initiation. The analysis of 61 squamous cell lung carcinomas shows that the percentage of carcinomas with a 3q27.1 amplification increases in higher malignant tumors. Non-invasive (T1) and minimal-invasive (T2) tumor stages showed similar percentages of amplified and non-amplified tumors, whereas locally-invasive (T3) tumors revealed a statistically significant (p < 0.05) increased percentage of amplified tumors. Microarrays were used to analyze the expression pattern of genes mapping in the amplified domain and its flanking regions (3q25-28) as well as the expression of genes directly or indirectly associated with translation initiation in squamous cell carcinoma, large cell carcinoma, adenocarcinoma and small cell carcinoma. Three genes, namely FXR1, CLAPM1 and EIF4G, are most frequently overexpressed in the center of the amplified domain in squamous cell carcinomas. The eukaryotic translation initiation factors 4A1, 2B and 4B as well as the poly(A)-binding protein PABPC1 where found to be overexpressed in all lung cancer entities. We found, however, no overexpression of eIF4E. Our results contribute to the understanding of the frequent amplification processes in squamous cell carcinomas of the lung and to the understanding of the translation initiation that appears not to require eIF4E in lung carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17290396     DOI: 10.1002/ijc.22585

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  46 in total

Review 1.  Genetic changes in squamous cell lung cancer: a review.

Authors:  Rebecca S Heist; Lecia V Sequist; Jeffrey A Engelman
Journal:  J Thorac Oncol       Date:  2012-05       Impact factor: 15.609

Review 2.  Translational control in cancer.

Authors:  Deborah Silvera; Silvia C Formenti; Robert J Schneider
Journal:  Nat Rev Cancer       Date:  2010-04       Impact factor: 60.716

3.  FXR1 is elevated in colorectal cancer and acts as an oncogene.

Authors:  Xin Jin; Bo Zhai; Taishi Fang; Xiaohui Guo; Lishan Xu
Journal:  Tumour Biol       Date:  2015-09-24

Review 4.  Role of translation initiation factor 4G in lifespan regulation and age-related health.

Authors:  Amber Howard; Aric N Rogers
Journal:  Ageing Res Rev       Date:  2014-01-03       Impact factor: 10.895

5.  Overexpression of eIF4F components in meningiomas and suppression of meningioma cell growth by inhibiting translation initiation.

Authors:  Janet L Oblinger; Sarah S Burns; Jie Huang; Li Pan; Yulin Ren; Rulong Shen; A Douglas Kinghorn; D Bradley Welling; Long-Sheng Chang
Journal:  Exp Neurol       Date:  2017-06-10       Impact factor: 5.330

6.  O-GlcNAcylation of core components of the translation initiation machinery regulates protein synthesis.

Authors:  Xuexia Li; Qiang Zhu; Xiaoliu Shi; Yaxian Cheng; Xueliu Li; Huan Xu; Xiaotao Duan; Linda C Hsieh-Wilson; Jennifer Chu; Jerry Pelletier; Maowei Ni; Zhiguo Zheng; Sihui Li; Wen Yi
Journal:  Proc Natl Acad Sci U S A       Date:  2019-04-02       Impact factor: 11.205

7.  RNA interference-mediated silencing of eukaryotic translation initiation factor 3, subunit B (EIF3B) gene expression inhibits proliferation of colon cancer cells.

Authors:  Zheng Wang; Jinxian Chen; Jianhua Sun; Zhe Cui; Hui Wu
Journal:  World J Surg Oncol       Date:  2012-06-26       Impact factor: 2.754

Review 8.  Targeting the translation machinery in cancer.

Authors:  Mamatha Bhat; Nathaniel Robichaud; Laura Hulea; Nahum Sonenberg; Jerry Pelletier; Ivan Topisirovic
Journal:  Nat Rev Drug Discov       Date:  2015-03-06       Impact factor: 84.694

9.  Over-expression of eukaryotic translation initiation factor 4 gamma 1 correlates with tumor progression and poor prognosis in nasopharyngeal carcinoma.

Authors:  Luxia Tu; Zhen Liu; Xiufang He; Ying He; Huiling Yang; Qingping Jiang; Siming Xie; Guanghui Xiao; Xin Li; Kaitai Yao; Weiyi Fang
Journal:  Mol Cancer       Date:  2010-04-16       Impact factor: 27.401

10.  Novel autoantigens immunogenic in COPD patients.

Authors:  Petra Leidinger; Andreas Keller; Sabrina Heisel; Nicole Ludwig; Stefanie Rheinheimer; Veronika Klein; Claudia Andres; Jürg Hamacher; Hanno Huwer; Bernhard Stephan; Ingo Stehle; Hans-Peter Lenhof; Eckart Meese
Journal:  Respir Res       Date:  2009-03-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.